Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma

Front Oncol. 2021 Mar 9:11:647809. doi: 10.3389/fonc.2021.647809. eCollection 2021.

Kai-Bin Yang^{1

2}, Cheng Xu², Yu-Pei Chen², Jan Baptist Vermorken^{3

4}, Brian O'Sullivan⁵, Jun Ma²

¹ Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
² State Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
³ Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.
⁴ Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
⁵ Department of Radiation Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.

No abstract available

Keywords: concurrent chemoradiotherapy; epstein barr virus; nasopharyngeal carcinoma; pathogenesis; recurrence; therapeutic strategies.

Publication types